Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22307566 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Phase IIb Trial of G-2535 (Unconjugated Isoflavones-100) in Women at High Risk for Breast Cancer
Condition: Breast Cancer
Interventions: Dietary Supplement: genistein;   Other: placebo

Indicates status has not been verified in more than two years